Document Detail

The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients.
Jump to Full Text
MedLine Citation:
PMID:  23818765     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Both Alzheimer's disease (AD) and cerebrovascular atherosclerosis (CA) contributed to dementia in an aged population. Whether they share the same mechanism is unknown.
AIM: Our goal was to explore the occurrence rates of CA in AD patients.
METHOD: Here we examined the degree of CA in different groups of AD patients with contrast angiography. Ninety-three AD patients were recruited to the present study. Contrast computed tomography scanning and contrast angiography were performed for CA analyses.
RESULT: We found that the cerebrovascular plaques were common in AD patients, which was partly correlated with the severity of AD (as determined by cognitive decline).
CONCLUSION: We concluded that vascular dementia may partly correlate with AD pathology.
Authors:
Jing Yuan; Ge Wen; Yingjia Li; Changxing Liu
Related Documents :
9630045 - Hla-dqb1 and drb1 alleles in egyptian children with steroid-sensitive nephrotic syndrome.
7519955 - High free and latent collagenase activity in psoriatic arthritis synovial fluids.
9081245 - Temporomandibular joint involvement in generalized osteoarthritis and rheumatoid arthri...
7441655 - Effect of oral zinc sulphate and penicillamine on zinc metabolism in patients with rheu...
14748805 - Antifungal prophylaxis with azole derivatives.
24430115 - Endovascular internal carotid artery trapping for ruptured blood blister-like aneurysms...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-5-24
Journal Detail:
Title:  Clinical interventions in aging     Volume:  8     ISSN:  1178-1998     ISO Abbreviation:  Clin Interv Aging     Publication Date:  2013  
Date Detail:
Created Date:  2013-7-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101273480     Medline TA:  Clin Interv Aging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  581-584     Citation Subset:  -    
Affiliation:
Department of Medical Information, General Hospital of Jinan Military Command, Jinan, People's Republic of China;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Clin Interv Aging
Journal ID (iso-abbrev): Clin Interv Aging
ISSN: 1176-9092
ISSN: 1178-1998
Publisher: Dove Medical Press
Article Information
Download PDF
© 2013 Yuan et al, publisher and licensee Dove Medical Press Ltd.
License:
Received Day: 23 Month: 5 Year: 2013
collection publication date: Year: 2013
Print publication date: Year: 2013
Electronic publication date: Day: 24 Month: 5 Year: 2013
Volume: 8First Page: 581 Last Page: 584
PubMed Id: 23818765
ID: 3693594
DOI: 10.2147/CIA.S44160
Publisher Id: cia-8-581

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
Jing Yuan1*
Ge Wen2*
Yingjia Li3
Changxing Liu1
1Department of Medical Information, General Hospital of Jinan Military Command, Jinan, People’s Republic of China;
2Imaging Center, Nanfang Hospital of Southern Medical University, Guangzhou, People’s Republic of China;
3Ultrasound Diagnosis Department, Nanfang Hospital of Southern Medical University, Guangzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Correspondence: Changxing Liu, Department of Medical Information, General Hospital of Jinan Military Command, No 25 Shifan Road, Jinan, 250031, People’s Republic of China, Email liu_aged@163.com

Introduction

Both Alzheimer’s disease (AD) and cerebrovascular atherosclerosis (CA) contributed to dementia in an aged population.13 Whether the two diseases share a common mechanism or pathological progression is yet unclear. It is proposed that in AD the amyloid beta peptide mutates and accumulates to form abnormal aggregates that are resistant to internal clearance,46 and these aggregates lead to amyloid plaques (senile plaques) that cause neuronal death as well as other pathological changes inside the brain, with final functional loss. Conversely, for the CA multiple small infarcts (atheromatous plaque) formed inside microvasculature and interrupted the microperfusion.79 This also leads to cognitive decline and memory loss as the final result.

Given the two distinct theories explaining the pathogenesis of AD and CA, there are increasing studies that show some common risk factors for both diseases, such as apolipoprotein E, age, smoking, inflammation, and body metabolism.2,1015 In addition, the coronary atherosclerosis cases are increased in patients with AD compared to those without.1618 Conceivably, the CA is higher in patients showing heart attack. Postmortem studies also reported the existence of CA in many AD patients. In the present study, we tried to employ radiological approach to investigate the occurrence of CA in AD patients.


Materials and methods
Clinical data

In the present study 93 AD patients were recruited in the Imaging Center, Nanfang Hospital of Southern Medical University, Guangzhou, People’s Republic of China (male, 61; female, 32; aged 59–82 years; average, 71.2 years old) from January 2012 to December 2012. The patients met the criteria of the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer’s Disease and Related Disorders Association for AD, with a clinical dementia rating of 0.5 ([early AD] 17 cases); or 1 ([mild AD] 26 cases); 2 ([moderate AD] 39 cases); or 3 ([severe AD] 11 cases) (Table 1).

The study was approved by the ethics committee of medical research on human subjects at the General Hospital of Jinan Military Command, and the researchers obtained written consent from all subjects as well as their family members.

Contrast computed tomography scanning and contrast angiography were performed, atherosclerotic lesions were registered, and diameter stenosis degrees were calculated.


Statistics

The data were represented as mean ± standard deviation and analyzed with the Statistical Package for the Social Sciences 16.0 software (SPSS; IBM Corporation, Armonk, NY, USA) for statistics. The t-test was used to compare intergroup differences, and P < 0.05 was considered statistically significant.


Results
Detection of cerebrovascular atherosclerosis

We found that atheromatous plaque is prevalent in AD patients: six of 17 (35.3%) in early AD; 14 of 26 (53.8%) in mild AD; 20 of 39 (51.3%) in moderate AD; and nine of eleven (81.8%) in severe AD. In addition, among these cases, both noncalcified and calcified atheromatous plaques were detected at different possibilities (Figure 1). The percentage of noncalcified mixed and calcified atheromatous plaques were 44%, 12%, and 44% in early AD; 47%, 21%, and 32% in mild AD; 39%, 15%, and 46% in moderate AD; and 22%, 35%, and 43% in severe AD (Figure 2).

Distribution of atheromatous plaques

We found that noncalcified atheromatous plaques were mainly distributed in the intracranial arteries (79.2%), mixed plaques in the intracranial arteries (19.1%), and intracranial internal carotid artery (ICA) (44.3%), calcified plaques in the intracranial ICA (55.2%), and extracranial arteries (24.7%) across the different AD groups. Interestingly, we found no obvious differences in plaque distribution across different staged AD patients (P > 0.05).

Results of atheromatous plaques as vessel occlusion

The differentially composed atheromatous plaques have been shown to be associated with different levels of vessel occlusion previously. The percentage of severe stenosis (>60%) and occlusion in the different AD groups were 3.1% (early), 6.7% (mild), 11.3% (moderate), and 10.7% (severe). The values were significantly different from the severe AD group to the early/mild AD groups.


Discussion

Few studies have examined the formation of CA plaques in AD patients, specifically.1,2,7,12 It has been shown that in an aged group with cognitive decline, atherosclerosis plaques could be used as the marker for vascular dementia.4,7,19 In the present study, we found that cerebrovascular plaques leading to stenosis or occlusion existed in AD patients as well. Therefore, the mixed AD/CA pathology should be considered and referred in clinical diagnosis of certain aged patients with cognitive decline.

The mechanisms underlying such interactions are yet unclear. The common risk factors, such as apolipoprotein E, age, smoking, inflammation, and body metabolism, do not fully explain the increased atheromatous plaque occurrence in severe AD, rather than in early AD patients.2,4,5,2023 We believe it is possible that the neuronal death and neuroinflammation in late-stage AD triggered the atheromatous plaque formation. If so, the neuroinflammation would act as the share mechanism in pathogenesis and progression in patients with severe dementia, providing the common drug target for both syndromes.

There are certain limitations of the present study. Currently, it is possible to perform magnetic resonance imaging and positron emission tomography for the tracing of plaque formation in the vessels, as well as of the amyloid plaques for AD patients.2426 It will be important to perform different tests on patients to correlate the changes of CA pathology with AD pathology (senile/amyloid plaque) progression. Additionally, we did not correlate other syndromes of vascular dementia into the clinical data of AD patients, taken together with the analysis of stenosis changes of the vessels.12,27 We expect to perform such studies in the future. Finally, it will be important to perform these examinations on aged-matched non-AD controls to see if AD pathology causes increased atheromatous plaque formation.

In conclusion, we believe that the vascular pathology may represent one common phenomenon in AD patients. The separation of AD and CA pathology might require reconsideration.


Notes

Disclosure

The authors report no conflicts of interest in this work.

The authors received funding from the Guangzhou Baiyun Kexunju Grant 2011-KZ-92.


References
1. Roher AE,Debbins JP,Malek-Ahmadi M,et al. Cerebral blood flow in Alzheimer’s diseaseVasc Health Risk ManagYear: 2012859961123109807
2. Altman R,Rutledge JC. The vascular contribution to Alzheimer’s diseaseClin Sci (Lond)Year: 20101191040742120684749
3. Kennelly SP,Lawlor BA,Kenny RA. Blood pressure and the risk for dementia: a double-edged swordAgeing Res RevYear: 200982617019063999
4. Honjo K,Black SE,Verhoeff NP. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascadeCan J Neurol SciYear: 201239671272823227576
5. Chu LW. Alzheimer’s disease: early diagnosis and treatmentHong Kong Med JYear: 201218322823722665688
6. Hooghiemstra AM,Eggermont LH,Scheltens P,van der Flier WM,Scherder EJ. Exercise and early-onset Alzheimer’s disease: theoretical considerationsDement Geriatr Cogn Dis ExtraYear: 2012213214522590474
7. Grinberg LT,Thal DR. Vascular pathology in the aged human brainActa NeuropatholYear: 2010119327729020155424
8. Veglio F,Paglieri C,Rabbia F,Bisbocci D,Bergui M,Cerrato P. Hypertension and cerebrovascular damageAtherosclerosisYear: 2009205233134119100549
9. Onyike CU. Cerebrovascular disease and dementiaInt Rev PsychiatryYear: 200618542343117085361
10. Yarchoan M,Xie SX,Kling MA,et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementiasBrainYear: 2012135Pt 123749375623204143
11. Orsucci D,Mancuso M,Ienco EC,Simoncini C,Siciliano G,Bonuccelli U. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer’s diseaseCurr Neurovasc ResYear: 2013101768023151073
12. Silvestrini M,Viticchi G,Falsetti L,et al. The role of carotid atherosclerosis in Alzheimer’s disease progressionJ Alzheimer’s DisYear: 201125471972621508532
13. Palacios HH,Yendluri BB,Parvathaneni K,et al. Mitochondrion-specific antioxidants as drug treatments for Alzheimer diseaseCNS Neurol Disord Drug TargetsYear: 201110214916221222631
14. Rocchi A,Orsucci D,Tognoni G,Ceravolo R,Siciliano G. The role of vascular factors in late-onset sporadic Alzheimer’s disease. Genetic and molecular aspectsCurr Alzheimer ResYear: 20096322423719519304
15. Jicha GA,Parisi JE,Dickson DW,et al. Age and apoE associations with complex pathologic features in Alzheimer’s diseaseJ Neurol SciYear: 20082731–2343918653200
16. Bhat NR. Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediatorsJ NeurochemYear: 2010115355156220807313
17. Beeri MS,Rapp M,Silverman JM,et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriersNeurologyYear: 20066691399140416682673
18. Kosunen O,Talasniemi S,Lehtovirta M,et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patientsStrokeYear: 19952657437487740560
19. Moretti R,Torre P,Antonello RM,Manganaro D,Vilotti C,Pizzolato G. Risk factors for vascular dementia: hypotension as a key pointVasc Health Risk ManagYear: 20084239540218561514
20. Weinstein G,Wolf PA,Beiser AS,Au R,Seshadri S. Risk estimations, risk factors, and genetic variants associated with Alzheimer’s disease in selected publications from the Framingham Heart StudyJ Alzheimers DisYear: 201333Suppl 1S439S44522796871
21. Cechetto DF,Hachinski V,Whitehead SN. Vascular risk factors and Alzheimer’s diseaseExpert Rev NeurotherYear: 20088574375018457531
22. Rafael H. Cerebral atherosclerosis and mild Alzheimer’s diseaseStrokeYear: 2003348e10612855821
23. Premkumar DR,Cohen DL,Hedera P,Friedland RP,Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s diseaseAm J PatholYear: 19961486208320958669492
24. Musiek ES,Saboury B,Mishra S,et al. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer’s diseaseHell J Nucl MedYear: 201215319019623106049
25. Westman E,Muehlboeck JS,Simmons A. Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversionNeuroimageYear: 201262122923822580170
26. Manook A,Yousefi BH,Willuweit A,et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s diseasePLoS OneYear: 201273e3131022427802
27. Kalback W,Esh C,Castano EM,et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s diseaseNeurol ResYear: 200426552553915265270

Article Categories:
  • Rapid Communication

Keywords: Alzheimer’s disease, cerebrovascular atherosclerosis, aging, patients.

Previous Document:  Do concomitant pain symptoms in patients with major depression affect quality of life even when taki...
Next Document:  Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsatur...